Clinical trial
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
NCT00446966 · Chirag Sandesara, Other · Completed
Key facts
| NCT number | NCT00446966 |
|---|---|
| Title | Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery |
| Official title | Fish Oil to Inhibit Supraventricular Arrhythmias After Cardiac Surgery: The Fish Trial |
| Acronym | FISH |
| Lead sponsor | Chirag Sandesara, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Omega Three Polyunsaturated fatty acids |
| Enrollment | 260 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Mar 13, 2007 |
| Last update posted | Oct 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: